This document discusses glaucoma, defining it as an eye disease characterized by loss of retinal ganglion cells and their axons caused by increased intraocular pressure. It is the leading cause of irreversible blindness. There are two main types - open angle glaucoma, the most common type, and angle closure glaucoma. Diagnosis involves measuring intraocular pressure and examining the optic nerve and visual field. Treatment options include eye drop medications, laser treatments, and surgeries like trabeculectomy to improve fluid drainage from the eye. Nursing care focuses on managing pain, allaying fears, and educating patients.
complete information about the refractive errors due to the problem in the acomodation of eye lense , disturbed image formation in the retina, contains -types of disease condition .
Refractive error means that the shape of your eye does not bend light correctly, resulting in a blurred image. The main types of refractive errors are myopia (nearsightedness), hyperopia (farsightedness), presbyopia (loss of near vision with age), and astigmatism.
This slide contains information regarding blepharitis, chalazion and stye. This can be helpful for proficiency level and bachelor level nursing students.
complete information about the refractive errors due to the problem in the acomodation of eye lense , disturbed image formation in the retina, contains -types of disease condition .
Refractive error means that the shape of your eye does not bend light correctly, resulting in a blurred image. The main types of refractive errors are myopia (nearsightedness), hyperopia (farsightedness), presbyopia (loss of near vision with age), and astigmatism.
This slide contains information regarding blepharitis, chalazion and stye. This can be helpful for proficiency level and bachelor level nursing students.
GLAUCOMA
,dignosis , types of glaucoma , risk factors oo glaucoma and treatment , the clasis of drugs that use in treatment of glaucoma.
prepared by : Hardi Sdiq
university of sullaimani
collage of pharmacy
A group of eye disorders, glaucoma is characterized by high intraocular pressure (IOP) that damages the optic nerve.
Glaucoma is one of the leading causes of irreversible blindness in the world and is the leading cause of blindness among adults in the United States.
Glaucoma may occur as primary or congenital disease or secondary to other causes, such as injury, infection, surgery, or prolonged use of topical corticosteroids.
Primary glaucoma has mainly two forms :
1. Open angle glaucoma ( chronic, simple, or wide angle glaucoma)
2. Angle –closure glaucoma( Acute or narrow angle glaucoma)
Angle –closure glaucoma occurs suddenly and may cause permanent or irreversible vision loss in 48 to 72 hours.
complete information about the retinal detachment , types, , symptoms , sign, etiology, causes, diagnosis, complications, medical management, nursing management, home care, patient teaching. nursing reserch.
GLAUCOMA
,dignosis , types of glaucoma , risk factors oo glaucoma and treatment , the clasis of drugs that use in treatment of glaucoma.
prepared by : Hardi Sdiq
university of sullaimani
collage of pharmacy
A group of eye disorders, glaucoma is characterized by high intraocular pressure (IOP) that damages the optic nerve.
Glaucoma is one of the leading causes of irreversible blindness in the world and is the leading cause of blindness among adults in the United States.
Glaucoma may occur as primary or congenital disease or secondary to other causes, such as injury, infection, surgery, or prolonged use of topical corticosteroids.
Primary glaucoma has mainly two forms :
1. Open angle glaucoma ( chronic, simple, or wide angle glaucoma)
2. Angle –closure glaucoma( Acute or narrow angle glaucoma)
Angle –closure glaucoma occurs suddenly and may cause permanent or irreversible vision loss in 48 to 72 hours.
complete information about the retinal detachment , types, , symptoms , sign, etiology, causes, diagnosis, complications, medical management, nursing management, home care, patient teaching. nursing reserch.
Glaucoma: the “silent thief of sight”
Glaucoma is a leading cause of preventable sight loss. Vision can often be preserved with early identification, good adherence to treatment and long-term monitoring.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
Glaucoma
1.
2. Introduction
Glaucoma is the second leading progressive ocular
disorder after cataract.
As glaucoma is asymptomatic, the patients are
unaware until noticeable vision loss occurs.
Due to its insidious nature, it is critical to detect
glaucoma at the earliest
3. Definition
Glaucoma is an eye disease characterized by the loss of
retinal ganglion cells and their axons.
Glaucoma is a group of ocular conditions characterized
by optic nerve damage. The optic nerve damage is
related to the intra ocular pressure (IOP) caused by
congestion of aqueous humor in the eye.
Brunner & Suddarth’s
4. Incidence
Glaucoma is the leading cause of irreversible
blindness. In fact, as many as 6 million individuals are
blind in both eyes from this disease.
6. Congenital infantile buphthalmos
hydrophthalmos
It is characterized by elevation of intra ocular pressure
(IOP) associated with developmental abnormalities of
the angle of anterior chamber depending upon the age
of onset.
7. Congenital infantile buphthalmos
hydrophthalmos
This developmental glaucoma’s are termed as:
1. True or primary congenital glaucoma (IOP is raised
during intrauterine life)
2. Infantile glaucoma’s (Diseases manifests prior to the
child)
3. Juvenile glaucoma (Children develop pressure rise
between 3-16 yrs of life).
8. OPEN ANGLE GLAUCOMA
It is the most common form of the disease and
generally does not affect people until they are in their
40s.
9. 1) Primary chronic open angle
glaucoma (COAG)
It is the most common type of the glaucoma. Its
frequency increases greatly with age. The aqueous
fluid does not drain from the eye properly. The
pressure within the eye, therefore, builds up painlessly
and without symptoms.
10. 2) Normal tension (pressure)
glaucoma or low tension
glaucoma
This type of glaucoma is thought to be due to decreased
blood flow to the optic nerve. This condition is
characterized by progressive optic-nerve damage and
loss of peripheral vision (visual field) despite
intraocular pressures in the normal range or even
below normal
11. 3) Childhood glaucoma
Childhood glaucoma is an uncommon pediatric
condition often associated with significant visual loss.
It may most commonly be caused by trauma, surgery
or other acquired or secondary causes or abnormal
increase intra ocular pressure.
12. 4) Secondary open angle
glaucoma
It can result from an eye (ocular) injury, inflammation
in the iris (iritis), rétinal vein blockage etc.
13. 5) Pigmentary glaucoma
In this granules of pigment detach from the iris, which
is the colored part of the eye. These granules then may
block the trabecular meshwork, is a key element in the
drainage system of the eye. Finally the blocked
drainage system leads to elevated intraocular pressure
which results in damage to the optic nerve.
14. 6) Exfoliative glaucoma
This type of glaucoma is characterized by deposits of
flaky material on the front surface of the lens (anterior
capsule) & in the angle of the eye. The accumulation of
this material in the angle is believed to block the
drainage system of the eye and raise the eye pressure.
15. ANGLE CLOSURE GLAUCOMA
Angle-closure glaucoma may be acute or chronic. The
common element in both is that the entire drainage
angle becomes anatomically closed, so that the
aqueous fluid within the eye cannot even reach all or
part of the trabecular meshwork.
16. 1) Acute angle closure glaucoma
When the drainage angle of the eye suddenly becomes
completely blocked, pressure builds up rapidly, and
this is called acute angle-closure glaucoma. The
symptoms include severe eye pain, blurred vision,
headache, nausea & vomiting.
17. 2) Chronic angle closure glaucoma
When the drainage angle of the eye gradually becomes
completely blocked, pressure builds up gradually, and
this is called chronic angle-closure glaucoma. The
drainage tissues gradually start to scar. This condition
is generally silent, and severe glaucoma damage can
occur without the person's knowledge.
19. Risk factors
1) Age over 45 years
2) Family history of glaucoma
3) Diabetes
4) History of elevated intra-ocular pressure
5) Near-sightedness (Myopia)
6) Use of steroids
7) Thin cornea
8) A history of severe anemia or shock
9) Cardiovascular disease
10) Eye trauma
11) Race
12) Abnormally high intra-ocular pressure
13) Peripheral vision is decreased.
14) Provision eye injury
15) Not seeing a rainbow.
20. Clinical manifestation
1) Severe eye pain
2) Eye redness
3) Blurred vision
4) Severe headache
5) Nausea
6) Vomiting
7) Dry eyes with itching or burning
8) Dark spot at the center of viewing
9) Excess tearing or watery eyes
10) Difficulty focusing on near or distant object
21. Pathophysiology
1. Initiating Events: - Precipitating factors include
illness, emotional stress, congenital narrow angles,
long term use of corticosteroids & mydriatics
(medications causing papillary dilation).These
events lead to second stage.
2. Structural alterations in the aqueous outflow
system: - Tissue & cellular changes caused by factors
that affect aqueous humor dynamics lead to structural
alterations & to the third stage
22. Pathophysiology
3. Functional alterations: - Conditions such as
increased IOP or impaired blood flow create
functional changes that lead to fourth stage.
4. Optic nerve damage: - Atrophy of the optic nerve is
characterized by loss of nerve fibers & blood supply &
this fourth stage inevitably progresses to the fifth
stage.
5. Vision loss: - Progressive loss of vision is
characterized by visual field defects.
25. Surgical management :-
1) Laser trabeculoplasty:
In this laser burns are applied to the inner surface of
the trabecular meshwork to open the intra trabecular
spaces.Thereby promoting outflow of aqueous humor
& decreasing IOP.The procedure is indicated when
IOP is inadequately controlled by medication’s serious
complication is a transient rise in IOP (usually 2
hrs.after surgery).
26. 2) Laser iridotomy :- ( for papillary
block glaucoma)
In this an opening is made in the iris to eliminate the
papillary block. This procedure is contraindicated in
pts with corneal edema.
Potential complication is burns to the cornea, lens or
retina, transient elevated IOP.
27. 3) Filtering procedures
These are used to create an opening or fistula in the
trabecular meshwork to drain aqueous humor from
the anterior chamber to the subconjunctival space,
thereby bypassing the usual drainage structures. This
allows the aqueous humor to flow & exit by different
routes.
28. 4) Trabeculectomy
It is the standard filtering technique used to remove
part of the trabecular meshwork. Complication
include hemorrhage, loe or elevated IOP, cataract etc.
29. 5) Drainage implants or shunts
These are an open tubes implanted in the anterior
chamber to shunt aqueous humor to an attached place
in the conjunctiva space. A fibrous capsule develops
around the episcleral plate & filters the aqueous
humor, thereby regulating the outflow & controlling
IOP.
30. 6) Canaloplasty
Canaloplasty utilizes a micro catheter or tube placed in
the Canal of Schlemm (the natural site of drainage for
healthy eyes) to enlarge the drainage canal, relieving
pressure inside the eye. Studies have been published
demonstrating longterm efficacy and safety
31. 7) Diode laser cycloablation
When trabeculectomy or glaucoma drainage tube
(seton) has failed to control glaucoma, then the
treating physician may consider cycloablation
(ablation or destruction of the ciliary body which
produces the aqueous fluid).Because cycloablation
involves permanent destruction of the ciliary body, it is
usually the last line of treatment for uncontrolled
glaucoma. Before the advent of laser, this was done
using a cry probe (freezing probe) to freeze the ciliary
body (cyclocryotherapy).
32. Nursing management :-
Acute pain related to increased intra-ocular pressure
Fear related to pain & potential loss of vision.
Nausea & vomiting related to opioids & other
medications.
Knowledge deficit related to disease